CN111543528A - Malus spectabilis granulated tea and preparation method and application thereof - Google Patents
Malus spectabilis granulated tea and preparation method and application thereof Download PDFInfo
- Publication number
- CN111543528A CN111543528A CN202010535541.XA CN202010535541A CN111543528A CN 111543528 A CN111543528 A CN 111543528A CN 202010535541 A CN202010535541 A CN 202010535541A CN 111543528 A CN111543528 A CN 111543528A
- Authority
- CN
- China
- Prior art keywords
- tea
- parts
- begonia
- sodium alginate
- granular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001481296 Malus spectabilis Species 0.000 title claims description 28
- 241001122767 Theaceae Species 0.000 title claims 15
- 238000002360 preparation method Methods 0.000 title abstract description 14
- 239000002245 particle Substances 0.000 claims abstract description 47
- 239000000463 material Substances 0.000 claims abstract description 28
- 241000218993 Begonia Species 0.000 claims abstract description 25
- 235000005087 Malus prunifolia Nutrition 0.000 claims abstract description 16
- 244000070406 Malus silvestris Species 0.000 claims abstract description 16
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 65
- 235000010413 sodium alginate Nutrition 0.000 claims description 64
- 229940005550 sodium alginate Drugs 0.000 claims description 64
- 239000000661 sodium alginate Substances 0.000 claims description 64
- 239000000843 powder Substances 0.000 claims description 52
- 239000007779 soft material Substances 0.000 claims description 42
- 238000001035 drying Methods 0.000 claims description 23
- 239000002994 raw material Substances 0.000 claims description 23
- 239000007864 aqueous solution Substances 0.000 claims description 22
- 239000008280 blood Substances 0.000 claims description 21
- 210000004369 blood Anatomy 0.000 claims description 21
- 238000004898 kneading Methods 0.000 claims description 19
- 238000002156 mixing Methods 0.000 claims description 19
- 238000010298 pulverizing process Methods 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 19
- 238000004806 packaging method and process Methods 0.000 claims description 18
- 238000005498 polishing Methods 0.000 claims description 18
- 230000001603 reducing effect Effects 0.000 claims description 15
- 240000002853 Nelumbo nucifera Species 0.000 claims description 14
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 14
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 13
- 239000008187 granular material Substances 0.000 claims description 9
- 241000213006 Angelica dahurica Species 0.000 claims description 8
- 240000000249 Morus alba Species 0.000 claims description 8
- 235000008708 Morus alba Nutrition 0.000 claims description 8
- 244000274050 Platycodon grandiflorum Species 0.000 claims description 8
- 241000205585 Aquilegia canadensis Species 0.000 claims description 7
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims description 7
- 244000046146 Pueraria lobata Species 0.000 claims description 7
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 238000001125 extrusion Methods 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims 1
- 244000269722 Thea sinensis Species 0.000 abstract description 95
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 25
- 235000014347 soups Nutrition 0.000 abstract description 15
- 230000035622 drinking Effects 0.000 abstract description 10
- 235000019658 bitter taste Nutrition 0.000 abstract description 7
- 235000019605 sweet taste sensations Nutrition 0.000 abstract description 4
- 239000000853 adhesive Substances 0.000 abstract description 3
- 230000001070 adhesive effect Effects 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 3
- 235000013616 tea Nutrition 0.000 description 91
- 239000000243 solution Substances 0.000 description 21
- 238000007873 sieving Methods 0.000 description 18
- 206010012601 diabetes mellitus Diseases 0.000 description 17
- 230000001954 sterilising effect Effects 0.000 description 17
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 9
- 241000628997 Flos Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 241000220225 Malus Species 0.000 description 5
- 229940126902 Phlorizin Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 description 5
- IOUVKUPGCMBWBT-GHRYLNIYSA-N phlorizin Chemical compound O[C@@H]1[C@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-GHRYLNIYSA-N 0.000 description 5
- 235000019139 phlorizin Nutrition 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 240000001396 Malus hupehensis Species 0.000 description 3
- 235000005057 Malus hupehensis Nutrition 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical class C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 229940118019 malondialdehyde Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000749874 Callicarpa formosana Species 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010012665 Diabetic gangrene Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 241000307676 Diploprion bifasciatum Species 0.000 description 1
- 208000030814 Eating disease Diseases 0.000 description 1
- 208000019454 Feeding and Eating disease Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 description 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 description 1
- 235000006751 Platycodon Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 102000003673 Symporters Human genes 0.000 description 1
- 108090000088 Symporters Proteins 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 201000011529 cardiovascular cancer Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 235000014632 disordered eating Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 206010062198 microangiopathy Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229930189914 platycodon Natural products 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a begonia granular tea and a preparation method and application thereof, belonging to the technical field of substitute tea products. The invention mixes the crabapple leaves and the substitutional tea evenly according to a certain proportion, and uses the framework material water solution as the adhesive to prepare the granular tea. The product has the advantages of smooth and round surface, uniform size, clear and transparent soup color, high tea extract content, bitter taste before sweet taste, stable release of particle contents, brewing resistance, small volume, exquisite package, convenience in carrying and drinking and the like, and meanwhile, the preparation process is scientific, precise and extremely suitable for large-scale industrial production, so that the product has good value of practical popularization and application.
Description
Technical Field
The invention belongs to the technical field of substitute tea products, and particularly relates to begonia granular tea and a preparation method and application thereof.
Background
The information in this background section is only for enhancement of understanding of the general background of the invention and is not necessarily to be construed as an admission or any form of suggestion that this information forms the prior art that is already known to a person of ordinary skill in the art.
Diabetes (Diabetes), which is called Diabetes by traditional Chinese medicine, is a series of clinical symptoms caused by absolute or relative insufficiency of insulin in vivo, is a common, frequent and lifelong disease, and is divided into type 1 Diabetes and type 2 Diabetes, wherein the proportion of the type 2 Diabetes is about 95%. The incidence rate of the disease tends to increase year by year, and the disease is classified as the third disease after cardiovascular diseases and tumors in developed countries. At present, the biggest harm of diabetes to the health of human beings is various chronic complications generated on the basis of arteriosclerosis and microangiopathy, such as diabetic heart disease, diabetic gangrene, diabetic cerebrovascular disease, diabetic nephropathy, diabetic retinopathy, neuropathy and the like. Diabetes causes the reduction of immunity and poor resistance of the organism of a patient, and is easy to induce respiratory tract infection, urinary tract infection and the like.
In the theory of traditional Chinese medicine, although there is no name of "diabetes", it belongs to the category of "diabetes" and "consumptive fever" in traditional Chinese medicine according to the characteristics of the onset of disease, clinical manifestations, development and prognosis. The "diabetes" is named from Huangdi's classic on the medical services of yellow emperor and also named as "Xiao Dan", and is considered to be related to the occurrence of the disease, mainly, the weakness of the five zang-organs, insufficient innate endowment, eating disorder and emotional impairment. Aiming at the pathogenesis and pathogenesis characteristics of diabetes, Ming Zhang Jing Yue proposes treating kidney, and the whole book of Jing Yue san xiao has the main causes: the treatment of diabetes is mainly to differentiate deficiency from excess, and if the true water is deficient, it is indicated for yin deficiency, so it is suitable for treating kidney in urgent cases, no matter upper, middle and lower, it must make yin qi gradually fill, essence and blood gradually recover, and then the disease is cured. If fire is cleared away, then yin will not grow but will gradually disappear, which is beneficial to . "Qing, Chenshize bell" Shi Chamber secret recording "cloud: there is no difference in the syndrome of diabetes, although it goes upward, middle and downward, but it is caused by kidney deficiency. Therefore, the treatment of the disease is mainly for the kidney, and it is not necessary to ask about the upper, middle and lower consumption. The theory of Cheng Zhong Ling (the age of Cheng Zhong in medicine Wu Gong) is: "Sanxiao" is a treatment without special measures for the essential meridian, but with nourishing the origin of its transformation, the disease is easily cured . Therefore, to address the pathogenesis of spleen and kidney deficiency, deficiency of both qi and yin, and blood stasis, and the experience of ancient and modern physicians in treating this disease, we have established the method of tonifying spleen and kidney, nourishing yin and quenching thirst. The spleen qi can be biochemically activated when healthy, the kidney yin can be restored when the kidney yin is restored, the healthy qi can be gradually restored, the qi and blood can be regulated, and the diabetes can be cured hopefully.
Hubei Chinese flowering crabapple (Malus hupehensis), commonly known as flower black tea, Malus multiflora, Malus yesii, Malus camellia, Malus hupehensis, Malus taishanensis and the like, belongs to deciduous trees of Malus genus of Rosaceae family, is widely distributed in Jiangsu, Zhejiang, Jiangxi, Hubei, Hunan, Shandong, Yunnan, Shaanxi and the like, and is rich in resources. Its tender leaves can be used as tea for drinking, and its drinking history in Hubei, Hunan and Jiangxi provinces has been over 400 years. In the Yili area of Shandong province, the leaf of Malus spectabilis is often used as tea for reducing blood sugar. The crabapple leaves contain a large amount of polyphenol components and various trace elements such as Fe, Cu, Zn, Cr, Mn and the like, and have the effects of resisting microorganisms, resisting anoxia, resisting fatigue, resisting oxidation, reducing blood sugar and the like. Hubei Malus spectabilis, originally recorded in the compendium of Xinhua materia Medica, the medicinal part is dry leaves. The function of crabapple leaves is described in the Chinese medicinal material Standard of Shandong province, which is recorded by the Chinese medicinal material Standard of Hubei province and the Chinese medicinal material Standard of Shandong province, as' nourishing liver and regulating stomach function, promoting fluid production to quench thirst, and removing food stagnation. Can be used for treating hypochondriac pain due to liver disease, diabetes, vertigo, etc. The "simultaneous" leaf of Malus hupehensis has been approved as a new food material. It can be used for long term to promote health. The crabapple leaves contain dihydrochalcone compounds such as phlorizin and phloretin, and pharmacodynamics research shows that the dihydrochalcone compounds mainly containing phlorizin are the main active ingredients for reducing blood sugar. Phlorizin can remarkably inhibit the levels of blood sugar (BG), serum Triglyceride (TG), Total Cholesterol (TC) and Malondialdehyde (MDA) in a diabetes model induced by alloxan, can enhance the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), and has good effects of reducing blood sugar and blood fat. The phlorizin has high-efficiency and specific inhibiting effect on sodium ion-glucose co-transporter participating in glucose absorption, thereby reducing the absorption of glucose in kidney and small intestine, promoting the excretion of glucose, and reducing fasting and postprandial blood glucose levels without generating hypoglycemia side effect; phlorizin can normalize insulin sensitivity in diabetic rats and eliminate or reduce insulin resistance caused by glucotoxicity.
The substitute tea is a product which can be drunk by using leaves, flowers, fruits, rhizomes and the like of plants in a tea-like drinking mode (drinking by soaking, boiling and the like). The substitute tea has certain health care effect. The current popular plant substitute tea on the market mainly comprises lotus leaves, honeysuckle, astragalus, schisandra, scutellaria, mulberry leaves, salvia, platycodon grandiflorum, jasmine, momordica grosvenori, ginkgo leaves, liquorice, gynostemma pentaphylla and the like. However, the inventor finds that although various plant raw materials are added into the current plant substitutional tea, the defects of complex preparation process, low tea extract content, poor taste after being brewed by tea water, low nutritional and health-care values and the like generally exist.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides the malus spectabilis granulated tea and the preparation method and the application thereof. The invention mixes the crabapple leaf and the substitute tea material evenly according to a certain proportion, and uses the framework material water solution as the adhesive to prepare the granular tea. The product has the advantages of smooth and round surface, uniform size, clear and bright soup color, high tea extract content, bitter taste first and sweet taste later, stable release of particle content, brewing resistance, small volume, exquisite package, convenient carrying and drinking, and the like, thereby having good value of practical popularization and application.
In order to achieve the purpose, the invention relates to the following technical scheme:
the invention provides a begonia granular tea, which is prepared from the following raw materials in parts by weight: 50-95 parts of Chinese flowering crabapple leaves, 3-45 parts of substitute tea raw materials and 2-5 parts of framework materials.
Wherein the substitute tea raw material is selected from at least one of lotus leaf, honeysuckle, kudzu root, rhizoma polygonati, mulberry leaf, angelica dahurica and platycodon root;
the framework material is selected from sodium alginate.
In a second aspect of the present invention, a preparation method of the crabapple granulated tea is provided, which comprises:
pulverizing folium Mali Pumilae and substitute tea into fine powder; mixing the two materials uniformly according to the weight ratio, adding the framework material aqueous solution, stirring and kneading to prepare a soft material;
and extruding and granulating the soft material to obtain the finished product.
In a third aspect of the invention, the application of the begonia granular tea in reducing blood sugar or preparing a product for reducing blood sugar is provided.
The beneficial technical effects of one or more technical schemes are as follows:
the crabapple granulated tea prepared by the technical scheme has the advantages of smooth and round surface, uniform size, clear and bright soup color, high tea extract content, bitter taste before sweetness, stable release of the contents in the granules, brewing resistance, small volume, exquisite package and convenience in carrying and drinking. Meanwhile, the preparation process is scientific, rigorous and extremely suitable for large-scale industrial production, so that the method has good practical popularization and application values.
Detailed Description
It is to be understood that the following detailed description is exemplary and is intended to provide further explanation of the invention as claimed. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
It is noted that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of exemplary embodiments according to the invention. As used herein, the singular forms "a", "an" and "the" are intended to include the plural forms as well, and it should be understood that when the terms "comprises" and/or "comprising" are used in this specification, they specify the presence of stated features, steps, operations, devices, components, and/or combinations thereof, unless the context clearly indicates otherwise. It is to be understood that the scope of the invention is not to be limited to the specific embodiments described below; it is also to be understood that the terminology used in the examples is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention.
As mentioned above, although various plant raw materials are added into the current plant substitutional tea, the defects of complex preparation process, low tea extract content, poor taste after being brewed by tea water, low nutritional and health-care values and the like generally exist.
In view of the above, in one embodiment of the present invention, a begonia granular tea is provided, which is composed of the following raw materials in parts by weight: 50-95 parts of Chinese flowering crabapple leaves, 3-45 parts of substitute tea raw materials and 2-5 parts of framework materials.
The substitute tea raw material is selected from at least one of lotus leaf, honeysuckle, kudzu root, rhizoma polygonati, mulberry leaf, angelica dahurica and platycodon grandiflorum.
The granular tea is prepared by wrapping substitute tea fine powder by using sodium alginate as a framework and an adhesive, a compact reticular structure is formed on the surface of granules by utilizing the biomacromolecule characteristic of polysaccharide, solid substances such as the substitute tea fine powder and the like are wrapped in the granular tea, and water molecules can freely enter and exit to ensure the stable release of extract. The product is resistant to brewing, and can be repeatedly brewed for more than 5 times; after the granular tea is soaked, the granular tea can quickly sink to the water bottom without affecting drinking.
In another embodiment of the invention, the begonia granular tea is prepared from the following raw materials in parts by weight: 80-95 parts of Chinese flowering crabapple leaves, 3-30 parts of substitute tea raw materials and 2-5 parts of framework materials. The inventor finds that the crabapple leaves have obvious blood sugar reducing effect through continuous experimental research, and if the crabapple leaves are added, the effect is reduced. The addition of the skeleton material (sodium alginate) is less than 2 parts by weight, the wettability of a soft material is reduced in the preparation process, the particle caking property is reduced, and the particle tea is not resistant to brewing and is easy to disperse.
Meanwhile, the bitter taste of the granular tea is lightened along with the increase of the adding proportion of the substitutive tea, but the bitter taste is obviously lightened when the adding amount of the substitutive tea is more than 45 parts by weight, and the adding amount of the substitutive tea is within 45 parts by weight for ensuring the efficacy of reducing blood sugar of the product.
In another embodiment of the invention, the particle size of the raw materials of the crabapple leaves and the substitutive tea is not more than 25 μm (sieving with a 500-mesh sieve). The raw materials of the crabapple leaves and the substitutional tea have more fibers, if the fineness is insufficient, the bonding in the soft material is poor, and the fibers are easy to appear on the surfaces of particles. The granule is easy to disperse when being brewed, so the crabapple leaf and the substitutional tea are crushed into fine powder and fed.
In another embodiment of the present invention, in order to ensure that the framework material (sodium alginate) forms a dense network structure on the surface of the granulated tea, the preferred particle size of the framework material (sodium alginate) is not more than 0.15 mm.
In another embodiment of the present invention, in order to sufficiently separate out the effective components, the particle size of the begonia granule tea of the present invention is preferably not more than 5.0mm, and preferably 2 to 5 mm.
In another embodiment of the present invention, a preparation method of the begonia granular tea is provided, which comprises:
pulverizing folium Mali Pumilae and substitute tea into fine powder; mixing the two materials uniformly according to the weight ratio, adding the framework material aqueous solution, stirring and kneading to prepare a soft material;
and extruding and granulating the soft material to obtain the finished product.
In another embodiment of the invention, the particle size of the fine powder of the crabapple leaves and the substitutional tea is not more than 25 μm (sieving by a 500-mesh sieve).
In another embodiment of the invention, the weight fraction of sodium alginate in the skeleton material aqueous solution is 3-4%; the inventor researches and discovers that jelly is easy to separate out when the sodium alginate aqueous solution is mixed with the crabapple leaf fine powder and the substitute tea fine powder to prepare soft materials; experiments show that when the raw material sodium alginate is fine powder (the particle size is not more than 0.15mm), the raw material sodium alginate is dissolved more quickly when being prepared into an aqueous sodium alginate solution, and jelly is not easy to separate out in the soft material preparation, so that the particle size of the sodium alginate is controlled to be not more than 0.15 mm.
In yet another embodiment of the present invention, the extrusion granulation is followed by the steps of drying, polishing and packaging.
In yet another embodiment of the present invention, the drying is performed by microwave drying, thereby performing sterilization simultaneously during the drying process.
In another embodiment of the invention, the application of the begonia granular tea in reducing blood sugar or preparing a product for reducing blood sugar is provided.
The invention is further illustrated by the following examples, which are not to be construed as limiting the invention thereto. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention. The raw materials in each embodiment mainly comprise Chinese flowering crabapple leaves, which are self-produced by tea mountain of the company; the lotus leaf is produced by lotus root garden of the company. Flos Lonicerae is derived from Taoist medicinal material in Yimeng mountain area; the other raw materials are all traditional Chinese medicine decoction pieces sold in the market.
Example 1
90 parts of Chinese flowering crabapple leaves, 5 parts of lotus leaves and 5 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae and folium Nelumbinis into fine powder with particle size not greater than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae fine powder and folium Nelumbinis fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 2
90 parts of Chinese flowering crabapple leaves, 7 parts of honeysuckle and 3 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae and flos Lonicerae into fine powder with particle size not more than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae fine powder and flos Lonicerae fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 3
85 parts of Chinese flowering crabapple leaves, 12.5 parts of kudzu roots and 2.5 parts of sodium alginate. Sodium alginate (particle diameter of 0.15mm) is prepared into 3% aqueous solution for standby. Pulverizing folium Mali Pumilae and radix Puerariae into fine powder with particle size not greater than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae fine powder and radix Puerariae fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 4
80 parts of begonia leaves, 18 parts of sealwort and 2 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae and folium Nelumbinis into fine powder with particle size not greater than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae fine powder and rhizoma Polygonati fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 5
90 parts of Chinese flowering crabapple leaves, 5 parts of mulberry leaves and 5 parts of sodium alginate. Sodium alginate (particle diameter of 0.15mm) is prepared into 3% aqueous solution for standby. Pulverizing folium Mali Pumilae and folium Mori into fine powder with particle size not greater than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae fine powder and folium Mori fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 6
80 parts of Chinese flowering crabapple leaves, 17 parts of angelica dahurica and 3 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae and radix Angelicae Dahuricae into fine powder with particle size not greater than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae fine powder and radix Angelicae Dahuricae fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 7
90 parts of Chinese flowering crabapple leaves, 7 parts of platycodon grandiflorum and 3 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae and radix Platycodi into fine powder with particle size not more than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae fine powder and radix Platycodi fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 8
80 parts of Chinese flowering crabapple leaves, 10 parts of lotus leaves, 7 parts of honeysuckle and 3 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae, folium Nelumbinis, and flos Lonicerae into fine powder with particle size not more than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae, folium Nelumbinis, and flos Lonicerae fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 9
80 parts of begonia leaves, 10 parts of lotus leaves, 7.5 parts of rhizoma polygonati and 2.5 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae, folium Nelumbinis, and flos Lonicerae into fine powder with particle size not more than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae, folium Nelumbinis, and flos Lonicerae fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 10
60 parts of Chinese flowering crabapple leaves, 25 parts of kudzu roots, 13 parts of rhizoma polygonati and 2 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae, radix Puerariae and rhizoma Polygonati into fine powder with particle size not more than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae, radix Puerariae and rhizoma Polygonati fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 11
70 parts of Chinese flowering crabapple leaves, 15 parts of mulberry leaves, 11 parts of angelica dahurica and 4 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae, folium Mori, and radix Angelicae Dahuricae into fine powder with particle size not more than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae, folium Mori and radix Angelicae Dahuricae fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 12
60 parts of Chinese flowering crabapple leaves, 20 parts of angelica dahurica, 17 parts of platycodon grandiflorum and 3 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae, radix Angelicae Dahuricae, and radix Platycodi into fine powder with particle size not more than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae, radix Angelicae Dahuricae, and radix Platycodi fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 13
70 parts of Chinese flowering crabapple leaves, 20 parts of lotus leaves, 6 parts of kudzu roots and 4 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae, folium Nelumbinis, and radix Puerariae into fine powder with particle size not greater than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae, folium Nelumbinis, and radix Puerariae fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 14
60 parts of Chinese flowering crabapple leaves, 20 parts of lotus leaves, 16 parts of mulberry leaves and 4 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae, folium Nelumbinis, and folium Mori into fine powder with particle size not greater than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae, folium Nelumbinis, and folium Mori fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 15
60 parts of Chinese flowering crabapple leaves, 30 parts of lotus leaves, 6 parts of angelica dahurica and 4 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae, folium Nelumbinis, and radix Angelicae Dahuricae into fine powder with particle size not more than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae, folium Nelumbinis, and radix Angelicae Dahuricae fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
Example 16
60 parts of Chinese flowering crabapple leaves, 30 parts of lotus leaves, 6 parts of platycodon grandiflorum and 4 parts of sodium alginate. Sodium alginate (particle size of 0.15mm) is prepared into 4% aqueous solution for later use. Pulverizing folium Mali Pumilae, folium Nelumbinis, and radix Platycodi into fine powder with particle size not more than 25 μm (sieving with 500 mesh sieve); mixing folium Mali Pumilae, folium Nelumbinis, and radix Platycodi fine powder, adding sodium alginate water solution, stirring, kneading, and making into soft material; squeezing the soft material, granulating, microwave drying, sterilizing, polishing, and packaging.
The granulated tea and the tea soup of the malus spectabilis granulated tea provided by the embodiment of the invention are subjected to drinking test scoring to obtain an analysis result.
The quality of the begonia granular tea product adopts an organoleptic scoring method, and the total score is 100 (40 scores of granular tea and 60 scores of tea soup). The granulated tea was first scored for 4 aspects of appearance, degree of breakage, aroma and roundness. Then 5g of the granular tea is put into a cup, about 300ml of boiling water is added, the tea is brewed for 20min, and the grading is carried out on 6 aspects of the color and luster, the transparency, the powder floating matter, the fragrance, the taste and the peculiar smell of the tea soup. The scoring criteria are shown in table 1.
TABLE 1 Callicarpa Formosana granulated tea sensory evaluation Standard
Randomly selecting 100 test drinkers to participate in scoring, and after counting scoring results through visual and olfactory observation of the test drinkers, evaluating the appearance of the granular tea by 96% of the test drinkers to be consistent in color and luster and uniform in size; 98% of the tasters considered the granular tea to be without pieces; 92% of the tasters considered the granulated tea to have a strong fragrance; 93% of the test drinkers considered the granular tea to have smooth and round surface. The overall evaluation of the granulated tea was good.
Then evaluating the tea soup brewed by the granular tea, evaluating test drinkers through taste, and counting the scoring results, wherein 98% of the test drinkers consider the tea soup to be orange yellow in color and transparent and bright; 92% of the test drinkers think that the granular tea has no floating objects after being brewed; 93% of the test drinkers think that the tea soup is aromatic; 97% of trial drinkers think that the tea soup is bitter and thick, bitter first and then sweet; 98% of the trial drinkers consider the tea soup to have no peculiar smell.
According to the evaluation of a drinker, the begonia granular tea provided by the embodiment of the invention has smooth and round surface, consistent color and uniform size; the tea soup has the advantages of clear and transparent color, high content of tea extract, bitter taste first and sweet taste later, stable release of particle content, brewing resistance, small volume, convenient carrying and drinking, and the like.
The test drinker rated the crabapple granulated tea provided in each example, and the scoring results are shown in table 2.
Table 2 example scoring results
| Item | Example 1 | Example 2 | Example 3 | Example 4 | Example 5 | Example 6 | Example 7 | Example 8 |
| Granulated tea (40 points) | 39 | 39 | 36 | 37 | 39 | 38 | 37 | 36 |
| Tea soup (60 points) | 59 | 58 | 58 | 58 | 56 | 56 | 57 | 58 |
| General score (100 points) | 98 | 97 | 94 | 95 | 95 | 94 | 94 | 94 |
Table 2 (continuation)
| Item | Example 9 | Example 10 | Example 11 | Example 12 | Example 13 | Example 14 | Example 15 | Example 16 |
| Granulated tea (40 points) | 38 | 39 | 39 | 36 | 38 | 37 | 38 | 38 |
| Tea soup (60 points) | 54 | 56 | 58 | 55 | 57 | 57 | 56 | 56 |
| General score (100 points) | 92 | 95 | 97 | 91 | 95 | 94 | 94 | 94 |
In conclusion, the invention provides the blood sugar-reducing begonia granular tea and the preparation method thereof, the blood sugar-reducing begonia granular tea is prepared from begonia leaves, substitutional tea (lotus leaves, honeysuckle, kudzu root, rhizoma polygonati, mulberry leaves, angelica dahurica, platycodon grandiflorum) and framework material (sodium alginate), and the granulation is carried out by utilizing the viscosity of the framework material (sodium alginate). The granule is brewed with boiling water for more than 5 times, has no loose granule, no floating powder, clear and transparent tea soup, rapid leaching and high content of effective components, and bitter taste before sweet taste. Not only has the blood sugar reducing effects of the Chinese flowering crabapple leaves, the substitutional tea and the sodium alginate, but also provides a novel tea product which is convenient to store, carry and brew for tea drinkers. The production steps are simple, the operability is high, the suitability with equipment is high, and the method can be applied to large-scale industrial production.
It should be noted that the above examples are only used to illustrate the technical solutions of the present invention and not to limit them. Although the present invention has been described in detail with reference to the examples given, those skilled in the art can modify the technical solution of the present invention as needed or equivalent substitutions without departing from the spirit and scope of the technical solution of the present invention.
Claims (10)
1. The begonia granular tea is characterized by comprising the following raw materials in parts by weight: 50-95 parts of Chinese flowering crabapple leaves, 3-45 parts of substitute tea raw materials and 2-5 parts of framework materials;
the substitute tea raw material is selected from at least one of lotus leaf, honeysuckle, kudzu root, rhizoma polygonati, mulberry leaf, angelica dahurica and platycodon grandiflorum;
the framework material is selected from sodium alginate.
2. The begonia granular tea as claimed in claim 1, which is prepared from the following raw materials in parts by weight: 80-95 parts of Chinese flowering crabapple leaves, 3-30 parts of substitute tea raw materials and 2-5 parts of framework materials.
3. The begonia granular tea as claimed in claim 1, wherein the particle size of the begonia leaf and substitute tea raw material is not more than 25 μm.
4. The begonia granular tea of claim 1, wherein the particle size of the matrix material is not greater than 0.15 mm.
5. The begonia granular tea as claimed in claim 1, wherein the granule diameter of the begonia granular tea is not more than 5.0 mm; preferably 2 to 5 mm.
6. The method for preparing the begonia granule tea of any one of claims 1 to 7, comprising:
pulverizing folium Mali Pumilae and substitute tea into fine powder; mixing the two materials uniformly according to the weight ratio, adding the framework material aqueous solution, stirring and kneading to prepare a soft material;
and extruding and granulating the soft material to obtain the finished product.
7. The method of claim 6, wherein the size of the fine powder of the crabapple leaf and the substitutional tea is not greater than 25 μm.
8. The method according to claim 6, wherein the weight fraction of sodium alginate in the aqueous solution of the framework material is 3-4%; the particle size of the sodium alginate raw material is controlled to be not more than 0.15 mm.
9. The method of claim 6, wherein the extrusion granulation is followed by the steps of drying, polishing and packaging;
preferably, the drying is performed by microwave drying.
10. Use of the begonia granule tea of any one of claims 1 to 5 for reducing blood sugar or for preparing a product for reducing blood sugar.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010535541.XA CN111543528A (en) | 2020-06-12 | 2020-06-12 | Malus spectabilis granulated tea and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010535541.XA CN111543528A (en) | 2020-06-12 | 2020-06-12 | Malus spectabilis granulated tea and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111543528A true CN111543528A (en) | 2020-08-18 |
Family
ID=71997339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010535541.XA Pending CN111543528A (en) | 2020-06-12 | 2020-06-12 | Malus spectabilis granulated tea and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111543528A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113273627A (en) * | 2021-05-26 | 2021-08-20 | 广西南宁杂谷阳堂健康科技有限公司 | Tea substitute capable of being placed in food for eating |
| CN113383839A (en) * | 2021-05-26 | 2021-09-14 | 德州健之源生物科技有限公司 | Preparation method of mulberry leaf health-care tea |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1247030A (en) * | 1998-09-08 | 2000-03-15 | 乌鲁木齐国际经济贸易公司 | Granular tea and production method thereof |
| CN103828965A (en) * | 2014-02-28 | 2014-06-04 | 徐星航 | Compound black tea granules and preparation method thereof |
| CN106720503A (en) * | 2016-12-02 | 2017-05-31 | 湖南惟楚福瑞达生物科技有限公司 | A kind of preparation method containing marine algae extract granular pattern black tea |
| CN109393120A (en) * | 2018-12-05 | 2019-03-01 | 余祚锟 | A kind of Malus spectabilis beverage tea prescription |
| CN109662314A (en) * | 2019-01-18 | 2019-04-23 | 青岛科技大学 | A kind of auxiliary hyperglycemic, compound Hubei Chinese flowering crabapple leaf functional food of reducing blood lipid and preparation method thereof |
-
2020
- 2020-06-12 CN CN202010535541.XA patent/CN111543528A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1247030A (en) * | 1998-09-08 | 2000-03-15 | 乌鲁木齐国际经济贸易公司 | Granular tea and production method thereof |
| CN103828965A (en) * | 2014-02-28 | 2014-06-04 | 徐星航 | Compound black tea granules and preparation method thereof |
| CN106720503A (en) * | 2016-12-02 | 2017-05-31 | 湖南惟楚福瑞达生物科技有限公司 | A kind of preparation method containing marine algae extract granular pattern black tea |
| CN109393120A (en) * | 2018-12-05 | 2019-03-01 | 余祚锟 | A kind of Malus spectabilis beverage tea prescription |
| CN109662314A (en) * | 2019-01-18 | 2019-04-23 | 青岛科技大学 | A kind of auxiliary hyperglycemic, compound Hubei Chinese flowering crabapple leaf functional food of reducing blood lipid and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113273627A (en) * | 2021-05-26 | 2021-08-20 | 广西南宁杂谷阳堂健康科技有限公司 | Tea substitute capable of being placed in food for eating |
| CN113383839A (en) * | 2021-05-26 | 2021-09-14 | 德州健之源生物科技有限公司 | Preparation method of mulberry leaf health-care tea |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101228911B (en) | Tea for nourishing face and eliminating toxin | |
| WO2018058851A1 (en) | Siraitia grosvenorii-prebiotics-chrysanthemum instant tea beverage and preparation method therefor | |
| CN103918830B (en) | A kind of warm tea beverage | |
| CN103478836B (en) | Plant beverage | |
| CN109645200A (en) | A kind of maca pressed candy and preparation method thereof | |
| CN102578648A (en) | Fruit juice beverage | |
| CN103444928B (en) | Morning tea bag for health preservation in spring | |
| CN105875938A (en) | Wild chrysanthemum tea and making method thereof | |
| CN106901122A (en) | A kind of houttuynia honeysuckle flower beverage particles and preparation method thereof | |
| CN111543528A (en) | Malus spectabilis granulated tea and preparation method and application thereof | |
| CN111418750A (en) | Polygonatum odoratum solid beverage and preparation method thereof | |
| CN100455215C (en) | Sobering pear juice beverage and its prepn. method | |
| CN106010877A (en) | Brewage method of mulberry fruit wine | |
| CN104757187A (en) | Green grass fruit and vegetable health tea and beverage and processing methods thereof | |
| CN103181560B (en) | Health food having effects of life cultivation and health preservation in winter and preparation method thereof | |
| CN103087882A (en) | Health-care wine and preparation method thereof | |
| CN102614401A (en) | Chinese medicinal compound potentilla chinensis powder or particle preparation for conditioning and treating emaciation-thirst disease | |
| CN105199929B (en) | A kind of strengthening spleen, tonifying kidney health liquor and preparation method thereof | |
| CN101919881A (en) | Preparation method of traditional Chinese medicine ointment | |
| CN102771595A (en) | Herbal cool and mellow tea and preparation method thereof | |
| CN106389776A (en) | Tropaeolum granule and preparation method thereof | |
| CN1076834A (en) | Preparation method of roxburgh rose body-building tea | |
| CN105248727A (en) | Compound tea beverage and preparation method thereof | |
| CN102696803B (en) | Jujube tea and method for preparing beverage of same | |
| CN108991195A (en) | A kind of pure plant Chinese herbal medicine health preserving tea and its preparation and drinking method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200818 |
|
| RJ01 | Rejection of invention patent application after publication |